JFIN Q4 2024 Earnings Strong EPS Performance Drives Stock Rally Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress ARHS Q1 2026 Earnings EPS Beats Expectations Amid Challenging Retail Environment Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue SOTK Q1 2026 Earnings EPS Misses Estimates by 216 Stock Rises 39 ALGT Q1 2026 Earnings EPS Surges Past Estimates with 1214 Beat Stock Slips Slightly